Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

127 ARTÍCULOS , VIENDO DEL 46 AL 60

Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease

Son HJ, Kim JS, Bateman RJ, Kim S, Llibre-Guerra JJ, Day GS, Chhatwal JP, Berman SB, Schofield PR, Jucker M, Levin J, Lee JH, Perrin RJ, Morris JC, Cruchaga C, Hassenstab J, Salloway SP, Lee JH, Daniels A; Dominantly Inherited Alzheimer Network (DIAN).

Neurology. 2024 Oct 8;103(7):e209766. doi: 10.1212/WNL.0000000000209766. Epub 2024 Sep 13.

Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data

Schroeder KM, Afonso AS, Wang H, Grace S, Phipps A, Sims JR.

J Alzheimers Dis. 2024 Nov;102(2):506-519. doi: 10.3233/JAD-231488. Epub 2024 Nov 13.

Evaluation of Sarcopenia screening indices as predictors of mortality in older patients with Alzheimer's disease

Song X, Huang S, Li M, Chen X.

BMC Geriatr. 2024 Dec 4;24(1):996. doi: 10.1186/s12877-024-05589-8.

Prevalence of ApoE Alleles in a Spanish Population of Patients with a Clinical Diagnosis of Alzheimer's Disease: An Observational Case-Control Study

Bello-Corral L, Seco-Calvo J, Molina Fresno A, González AI, Llorente A, Fernández-Lázaro D, Sánchez-Valdeón L.

Medicina (Kaunas). 2024 Nov 25;60(12):1941. doi: 10.3390/medicina60121941.

Addressing Healthy Aging: Time to Stop a Tsunami of Rising Alzheimer's Disease

Zong NC, Zhang Y, Huang Y, Cai H.

Aging Dis. 2024 Nov 28;16(6):3229-3232. doi: 10.14336/AD.2024.1476.

A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives

Na S, Lee C, Ho S, Hong YJ, Jeong JH, Park KH, Kim S, Wang MJ, Choi SH, Han S, Kang SW, Kang S, Yang DW.

J Alzheimers Dis. 2024;97(1):193-204. doi: 10.3233/JAD-230667.

Long-term antipsychotic use, orthostatic hypotension and falls in older adults with Alzheimer's disease

Dyer AH, Murphy C, Dolphin H, Morrison L, Briggs R, Lawlor B, Kennelly SP; NILVAD Study Group.

Eur Geriatr Med. 2024 Apr;15(2):527-537. doi: 10.1007/s41999-023-00910-x. Epub 2024 Jan 2.

The National Institutes of Health INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project: Accelerating research discoveries for people with Down syndrome across the lifespan

Bardhan S, Li H, Tarver E, Schramm C, Brown M, Garcia L, Schwartz B, Mazzucco A, Natarajan N, Walsh E, Ryan L, Pearson G, Parisi MA.

Am J Med Genet C Semin Med Genet. 2024 Mar;196(1):e32081. doi: 10.1002/ajmg.c.32081. Epub 2024 Jan 10.

Associations between antipsychotics exposure and dementia risk: A prospective cohort study of 415,100 participants

Ma LY, Ou YN, Gao PY, Fu Y, Zhang DD, Yang L, Feng JF, Cheng W, Tan L, Yu JT.

J Affect Disord. 2024 Mar 15;349:201-209. doi: 10.1016/j.jad.2024.01.029. Epub 2024 Jan 8.

Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population

Liu Y, Jun H, Becker A, Wallick C, Mattke S.

J Prev Alzheimers Dis. 2024;11(1):7-12. doi: 10.14283/jpad.2023.131.

Age of hypertension onset and cognitive function in the elderly: an observational study from the NHANES 2011-2014

Wu M, Lu C, Chen F, Fan Y, Li G, Zhou L.

Eur Geriatr Med. 2024 Apr;15(2):561-570. doi: 10.1007/s41999-023-00920-9. Epub 2024 Jan 17.

The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing

Liu Y, Tan Y, Zhang Z, Yi M, Zhu L, Peng W.

Transl Neurodegener. 2024 Jan 23;13(1):7. doi: 10.1186/s40035-024-00397-x.

Update on modifiable risk factors for Alzheimer's disease and related dementias

Jaisa-Aad M, Muñoz-Castro C, Serrano-Pozo A.

Curr Opin Neurol. 2024 Apr 1;37(2):166-181. doi: 10.1097/WCO.0000000000001243. Epub 2024 Jan 24.

Dementia in the Ancient Greco-Roman World Was Minimally Mentioned

Finch CE, Burstein SM.

J Alzheimers Dis. 2024;97(4):1581-1588. doi: 10.3233/JAD-230993.

A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol

Barbera M, Lehtisalo J, Perera D, Aspö M, Cross M, De Jager Loots CA, Falaschetti E, Friel N, Luchsinger JA, Gavelin HM, Peltonen M, Price G, Neely AS, Thunborg C, Tuomilehto J, Mangialasche F, Middleton L, Ngandu T, Solomon A, Kivipelto M; MET-FINGER study team.

Alzheimers Res Ther. 2024 Jan 31;16(1):23. doi: 10.1186/s13195-023-01355-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias